PDGF-B or PDGF receptor (PDGFR)-β, or genetic deletion of PDGFR-β in rodents or nonhuman primates have demonstrated that PDGFR-β signaling contributes to ≤80% of SMC migration and accumulation after acute vascular injury. 2, 3 Consistent with this evidence, exogenously administered PDGF-BB into the rat carotid artery after endothelial denudation increased neointimal lesions. 2, 4 In addition, genetic deletion of PDGFR-β decreased SMC accumulation in atherosclerotic lesions. 2,5 This accumulating evidence suggests that PDGF-BB and PDGFR-β signaling play a prominent role in vascular SMC migration into the neointima after vascular injury and during the development of atherosclerosis. 2 It has been suggested that PDGF-BB-mediated cell migration is attributed to the activation of intracellular signal transduction pathways, including phosphatidylinositol 3-kinase, mitogen-activated protein kinase cascade, and Objective-Vascular smooth muscle cell (SMC) migration causes neointima, which is related to vascular remodeling after mechanical injury and atherosclerosis development. We previously reported that an exchange protein activated by cAMP (Epac) 1 was upregulated in mouse arterial neointima and promoted SMC migration. In this study, we examined the molecular mechanisms of Epac1-induced SMC migration and the effect of Epac1 deficiency on vascular remodeling in vivo. Approach and Results-Platelet-derived growth factor-BB promoted a 2-fold increase in SMC migration in a primary culture of aortic SMCs obtained from Epac1 +/+ mice (Epac1 +/+ -ASMCs), whereas there was only a 1.2-fold increase in Epac1 −/− -ASMCs. The degree of platelet-derived growth factor-BB-induced increase in intracellular Ca 2+ was smaller in Fura2-labeled Epac1 −/− -ASMCs than in Epac1 +/+ -ASMCs. In Epac1 +/+ -ASMCs, an Epac-selective cAMP analog or platelet-derived growth factor-BB increased lamellipodia accompanied by cofilin dephosphorylation, which is induced by Ca 2+ signaling, whereas these effects were rarely observed in Epac1 −/− -ASMCs. Furthermore, 4 weeks after femoral artery injury, prominent neointima were formed in Epac1 +/+ mice, whereas neointima formation was significantly attenuated in Epac1 −/− mice in which dephosphorylation of cofilin was inhibited. The chimeric mice generated by bone marrow cell transplantation from Epac1 +/+ into Epac1 −/− mice and vice versa demonstrated that the genetic background of vascular tissues, including SMCs rather than of bone marrow-derived cells affected Epac1-mediated neointima formation. Conclusions-These data suggest that Epac1 deficiency attenuates neointima formation through, at least in part, inhibition of SMC migration, in which a decrease in Ca 2+ influx and a suppression of cofilin-mediated lamellipodia formation occur. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
I ntimal thickening occurs after injury to the luminal surface of arteries during percutaneous transmural angioplasty and coronary artery stenting, as well as during coronary artery bypass vein grafting. 1 Excessive intimal thickening leads to the failure of these interventions. Intimal thickening is also associated with early-and advanced-stage atherosclerotic lesions. 1 Despite the relative success of drug-eluting stents and pharmacological regimens to lower cholesterol levels, therapeutic strategies to obstructive arterial remodeling have not been fully established. 2 Arterial smooth muscle cell (SMC) migration to the intima is a fundamental process that leads to intimal thickening in diseased vessels and plays an important role in the pathogenesis of vascular stenosis and occlusion. 1, 3, 4 Platelet-derived growth factor (PDGF)-BB is released at the vascular injury sites and atherosclerotic lesions. 2 Studies using a blockade of extracellular signal-regulated kinase. 6, 7 In addition to these signaling pathways, it has been recognized that PDGF-BB increases intracellular cAMP via a G protein-coupled receptor transactivation mechanism. 8, 9 However, the role of PDGF-BB-induced cAMP in SMC migration remains unknown.
A major second messenger cAMP activates protein kinase A (PKA) and an exchange protein activated by cAMP (Epac). 10 Epac has 2 isoforms, Epac1 and Epac2, both of which are activated in living cells by physiologically relevant concentrations of cAMP. 10 Epac1 was found to be expressed in most tissues, including the blood vessels, whereas Epac2 is localized in the adrenal gland and the brain. 10 In our previous study, we demonstrated that Epac1 expression was increased in the area of intimal thickening after mouse femoral arteries were injured, and Epac1 activation promoted vascular SMC migration. 11 On the basis of these studies, we hypothesized that Epac1 was involved in PDGF-BB-induced SMC migration and neointimal thickening. In this study, we examined the molecular mechanisms of Epac1-induced migration using a primary culture of SMCs from Epac1-deficient (Epac1 −/− ) mice. 12 We also investigated whether Epac1 deficiency inhibited neointimal formation after vascular injury in vivo.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Epac1 Deficiency Attenuated Vascular SMC Migration
First, we examined PDGF-BB-mediated cAMP production in aortic SMCs from Epac1 +/+ (Epac1 +/+ -ASMCs) and Epac1 −/− mice (Epac1 −/− -ASMCs). In accordance with the previous reports on vascular SMCs, 8, 9 stimulation of PDGF-BB led to a 1.30±0.07fold increase in intracellular cAMP in Epac1 +/+ -ASMCs (P<0.05 versus control of Epac1 +/+ -ASMCs, n=6). A similar effect of PDGF-BB on cAMP production was also detected in Epac1 −/− -ASMCs (1.30±0.02-fold; P<0.01 versus control of Epac1 −/− -ASMCs; n=6). Subsequent PKA activation induced by PDGF-BB similarly occurred in both Epac1 +/+ -ASMCs (2.90±0.22-fold; P<0.001 versus control; n=6) and Epac1 −/− -ASMCs (2.98±0.13fold; P<0.001 versus control; n=6).
Because there was no significant difference in the effects of PDGF-BB on cAMP production between Epac1 +/+ -and Epac1 −/− -ASMCs (P=0.50; n=6), we examined the migratory effect of PDGF-BB on Epac1 +/+ -ASMCs and Epac1 −/− -ASMCs. In the basal condition, cell migration determined by total path length of ASMCs was similar in both Epac1 +/+--ASMCs and Epac1 −/− -ASMCs ( Figure 1A and 1B; Movies I-IV in the online-only Data Supplement). In Epac1 +/+ -ASMCs, PDGF-BB significantly promoted migration, whereas PDGF-BB-induced migration was significantly attenuated in Epac1 −/− -ASMCs ( Figure 1A and 1B; Movies I-IV in the online-only Data Supplement). Furthermore, PDGF-BB promoted the invasion of Epac1 −/− -ASMCs across Matrigel-coated filters, whereas this effect was significantly attenuated in Epac1 −/− -ASMCs ( Figure I in the online-only Data Supplement). The expression level of PDGFR-β, which primarily contributes to PDGF-BB-induced vascular SMC migration, 2 did not differ between Epac1 +/+ -and Epac1 −/− -ASMCs (0.72±0.12 and 0.53±0.04 arbitrary unit; P=0.20; n=4). Therefore, these data suggest that Epac1 is involved in PDGF-BB-induced vascular SMC migration.
Epac1 Deficiency Decreased PDGF-BB-Induced Intracellular Ca 2+ Elevation
It is well recognized that PDGF-mediated intracellular Ca 2+ elevation regulates cell migration. 13 of Epac1 increases intracellular Ca 2+ concentration by activating Ras-related protein (Rap)-phospholipase C (PLC)ε signaling, 15, 16 we investigated whether Epac1 was involved in the PDGF-BB-mediated increase in intracellular Ca 2+ concentration. Intracellular Ca 2+ concentrations acquired by monitoring Fura2-AM were significantly increased in PDGF-BB-stimulated Epac1 +/+ -ASMCs (Figure 2A and B) . In Epac1 −/− -ASMCs, however, PDGF-BB-mediated intracellular Ca 2+ elevation was significantly attenuated (Figure 2A and 2B) Ionomycin, which was used as a positive control, significantly increased intracellular Ca 2+ in both Epac1 +/+ -and Epac1 −/− -ASMCs. These data suggest that Epac1 is involved in PDGF-BB-induced intracellular Ca 2+ elevation in vascular SMCs.
Epac Stimulation Increased Lamellipodia Formation
Migrating cells are polarized with membrane protrusions at the leading edge. 17 Protrusion with lamellipodial growth forms new adhesions and plays crucial roles in cell migration. It is well recognized that the elevation of intracellular Ca 2+ concentration dephosphorylates cofilin 18, 19 to form lamellipodia by accelerating actin filament turnover. 17 To assess the role of Epac in the establishment of lamellipodia formation, lamellipodia accompanied by dephosphorylated cofilin in ASMCs was evaluated by immunocytochemistry. In untreated Epac1 +/+ -ASMCs, cofilin phosphorylation was maintained at the cell membrane, and lamellipodia were not formed in >80% of cells ( Figure 3A In accordance with these immunocytochemistry data, Western blotting analysis revealed that 8-pCPT-2-O-Me-cAMP significantly decreased phosphorylated cofilin protein expression in Epac1 +/+ -ASMCs but not in Epac1 −/− -ASMCs ( Figure 3C and 3D). Motile cells typically contain fewer, thinner, and more dynamic stress fibers. 20 Stimulation of Epac decreased F-actin stress fibers in Epac1 +/+ -ASMCs ( Figure 3A ). In contrast, in Epac1 −/− -ASMCs, stress fibers seemed to be increased in the basal condition, and 8-pCPT-2-O-Me-cAMP did not affect stress fiber formation ( Figure 3A) , which is consistent with the previous reports 21, 22 showing that Epac inhibits RhoA via Rap1, resulting in decreased stress fiber formation.
Epac1-Rap1a Is Involved in PDGF-BB-Induced Lamellipodia Formation
On the basis of the above findings, Epac1 seems to play a role in migration through regulation of lamellipodia formation. On binding of cAMP, Epac stimulates the exchange GDP for GTP on Rap1, followed by a PLCε-mediated increase in intracellular Ca 2+ . 15, 16 In our previous reports, we demonstrated that Epac1 activates Rap1 in vascular SMCs. 11 We then examined the involvement of Epac1 and the subtype-specific effect of Rap1 in lamellipodia formation using Epac1 +/+ -and Epac1 −/− -ASMCs. Rap1-targeted siRNAs significantly decreased expression levels of Rap1a in Epac1 +/+ -ASMCs (0.12±0.01-fold versus control siRNA; P<0.001; n=4) and Epac1 −/− -ASMCs (0.15±0.01-fold versus control siRNA; P<0.001; n=4) but not of Rap1b in Epac1 +/+ -ASMCs (0.99±0.06-fold versus control siRNA, n=4) and Epac1 −/− -ASMCs (1.10±0.07-fold versus control siRNA, n=4). Under transfection of control siRNAs, PDGF-BB increased the number of lamellipodia accompanied by dephosphorylated cofilin in Epac1 +/+ -ASMCs but not in Epac1 −/− -ASMCs ( Figure 4A and 4B ). In accordance with this result, Western blotting using wholecell lysates showed that PDGF-BB decreased phosphorylation of cofilin expression in Epac1 +/+ -ASMCs transfected with control siRNAs but not in Epac1 −/− -ASMCs ( Figure 4C and 4D). We confirmed similar findings of immunocytochemistry and Western blotting in untransfected Epac1 +/+and Epac1 −/− -ASMCs ( Figure II in the online-only Data Supplement). These data suggest that Epac1 was involved in the PDGF-mediated dephospholylation of cofilin and the subsequent lamellipodia formation.
Rap1a-targeted siRNAs significantly attenuated PDGF-BB-induced lamellipodia formation in Epac1 +/+ -ASMCs ( Figure 4A and 4B). In Epac1 −/− -ASMCs, Rap1a-targeted siRNA did not affect lamellipodia formation ( Figure 4A and 4B). We observed similar findings using another set of Rap1a-targeted siRNA ( Figure III in the online-only Data Supplement). In addition, Rap1a-targeted siRNAs attenuated PDGF-BB-mediated downregulation of phosphorylation of cofilin in whole-cell lysates of Epac1 +/+ -ASMCs, but the silencing of Rap1a did not affect cofilin phosphorylation in Epac1 −/− -ASMCs ( Figure 4C and 4D) . These data suggest that Epac1-Rap1a is involved in PDGF-BB-induced cofilin dephosphorylation and lamellipodia formation.
Neointimal Thickening Was Attenuated in Epac1 −/− Mice
Our in vitro data suggested that a deficiency of Epac1 attenuated PDGF-BB-induced migration in vascular SMCs. We therefore examined the effect of Epac1 deficiency on the neointimal thickening in vivo. There was no morphological difference between the femoral arteries of Epac1 +/+ , Epac1 heterozygous deficiency (Epac1 +/-), or Epac1 −/− mice under basal conditions ( Figure 5A , top). After 4 weeks, transluminal mechanical injury was induced in femoral arteries, prominent neointimal thickening formation was observed in Epac1 +/+ mice, whereas neointimal thickening formation was less pronounced in Epac1 −/− than in Epac1 +/+ mice ( Figure 5A , bottom). The quantitative data also demonstrated that intima cross-sectional area was smaller in Epac1 −/− than in Epac1 +/+ mice ( Figure 5B ). Because media thickness was similar in Epac1 +/+ and Epac1 −/− mice, the ratio of the area of neointimal thickening to that of the smooth muscle layer was smaller in Epac1 −/− than in Epac1 +/+ mice, and the internal lumen was significantly greater in Epac1 −/− than in Epac1 +/+ mice ( Figure 5B ). Although there was no statistical difference in wire injury-induced intimal thickening between Epac1 +/+ and Epac1 +/mice, the intimal thickening of Epac1 +/mice seemed moderately suppressed ( Figure 5B ).
Neointima formation was significantly developed at 2 weeks after injury, and it reached a maximum ≈4 weeks after injury in Epac1 +/+ mice ( Figure 5C ). However, for Epac1 −/− mice, only slight neointima formation was observed at 2 weeks after injury, and this formation was not as developed as in Epac1 +/+ mice at even 4 weeks after injury ( Figure 5C ). Furthermore, immunofluorescence staining using an antiphosphorylated cofilin antibody revealed that levels of p-cofilin expression were smaller in the area of intimal thickening in Epac1 +/+ than in Epac1 −/− mice. Similar changes in p-cofilin expression were observed in the medial layer of Epac1 +/+ and Epac1 −/− mice, although the degree of changes was moderate compared with that of the intimal thickening area ( Figure 5C ), which is in accordance with the in vitro data.
Neointimal thickening is attributed to multiple cellular mechanisms in SMCs, such as proliferation and phenotypic modulation. [21] [22] [23] Because the previous reports suggest that Epac1 inhibits SMC proliferation in vitro, 21, 22 we examined Figure IVA in the online-only Data Supplement). These in vitro data are consistent with the previous reports. 21, 22 However, immunohistochemistry using an anti-Ki67 antibody did not detect an increase in proliferative cells in injured Epac1 −/− arteries compared with injured Epac1 +/+ arteries ( Figure IVB in the online-only Data Supplement). Phenotypic modulation of SMCs, especially the upregulation of myosin heavy chain isoform SMemb, is well recognized in injured arteries. 23 The expression level of SMemb mRNA did not differ between Epac1 +/+ -and Epac1 −/− -ASMCs ( Figure VA in the online-only Data Supplement). SMemb protein expression was also similar in both injured Epac1 +/+ -and Epac1 −/− -arteries ( Figure VB in the online-only Data Supplement), suggesting that Epac1 did not directly modulate the SMC dedifferentiation marker.
SMC proliferation in vitro and in vivo, and found that Epac1 deficiency promotes fetal bovine serum-induced SMC proliferation in vitro (
Involvement of Vascular Tissue Rather Than Bone Marrow-Derived Cells in Epac1-Mediated Neointimal Thickening
In addition to the role of SMC migration, it has been demonstrated that bone marrow-derived cells (BMCs) and perivascular fibroblasts contribute to intimal thickening. 24, 25 We, therefore, performed total BMC transplantation after irradiation from Epac1 +/+ into Epac1 −/− mice and vice versa (Epac1 −/− recipient and Epac +/+ recipient, respectively). Successful reconstitution of transplanted bone marrow was demonstrated by a shift in the Ly-antigen expression on peripheral blood CD11b-positive cells 4 weeks after transplantation using FACS (fluorescence activated cell sorting) analysis. Ly5.1 was expressed on Epac1 +/+ CD11b-positive cells, whereas Ly5.2 was expressed on Epac1 −/− CD11b-positive cells ( Figure  6A ). According to each donor BMCs, we found exclusive Ly5.1 expression (98.8±0.3%) in mice with Epac1 −/− recipient CD11b-positive cells and exclusive Ly5.2 expression (98.8±0.5%) in mice with Epac1 +/+ recipient CD11b-positive cells in peripheral blood samples ( Figure 6B ). As a sham control, we transplanted BMCs from Epac1 +/+ into Epac1 +/+ mice (Epac +/+ sham) and from Epac1 −/− into Epac1 −/− mice (Epac −/− sham). After reconstitution, we induced vascular injury of the femoral arteries in the transplanted mice and analyzed vascular remodeling 4 weeks after arterial injury. Morphometric analysis revealed that Epac1 −/− recipient (bone marrow: Epac +/+ ) and Epac1 −/− sham exhibited significant reduction of intimal thickening compared with Epac +/+ sham. However, reduction of intimal thickening in Epac1 +/+ recipient (bone marrow: Epac −/− ) compared with Epac +/+ sham did not reach a statistical difference ( Figures 6C and 6D) . These data suggest that the extent of intimal thickening was significantly associated with the genetic background of the vascular tissues, such as SMCs and perivascular fibroblasts, rather than with that of BMCs.
In addition to the migratory roles of SMCs, perivascular fibroblast migration is implicated in contributing to intimal thickening. 25 To examine the role of Epac1 in perivascular fibroblasts, we performed a migration assay using a primary culture of periaortic fibroblasts of Epac +/+ and Epac −/− mice. In the basal condition, cell migration determined by total path length of ASMC was similar in both Epac1 +/+ -and Epac1 −/−fibroblasts ( Figure VI in the online-only Data Supplement). In Epac1 +/+ fibroblasts, PDGF-BB significantly promoted migration, whereas PDGF-BB-induced migration was significantly attenuated in Epac1 -/fibroblasts ( Figure VI in the online-only Data Supplement).
Together with in vitro data, these data suggest that Epac1 in SMCs plays an important role in intimal thickening, and perivascular fibroblasts may contribute to intimal thickening as well.
Discussion
We demonstrated, using Epac1-deficient vascular SMCs, that PDGF-BB-induced intracellular Ca 2+ elevation, lamellipodia formation accompanied by dephosphorylated cofilin, and migration were significantly attenuated. Conversely, this study showed in Epac1 +/+ -ASMCs that stimulation of Epac promoted lamellipodia formation accompanied by dephosphorylated cofilin and that PDGF-BB-induced lamellipodia formation was inhibited by the silencing of Rap1a. These data suggested that Epac1 promoted cofilin dephosphorylation, and thus promoted lamellipodia formation and subsequent vascular SMC migration. In accordance with these in vitro data, the in vivo study revealed that Epac1 deficiency inhibited vascular injury-induced intimal thickening in which cofilin dephosphorylation was inhibited.
PDGF-BB is a potent stimulator that promotes migration in various cell types and plays a prominent role in neointimal thickening. 2, 14 It has also been reported that 2 single-nucleotide polymorphisms located in the PDGF-B gene were associated with cardiac allograft vasculopathy, which is a condition of atherosclerotic-like changes in the coronary arteries. 26 During the development of intimal thickening, multiple signaling pathways of PDGF-induced migration such as phosphatidylinositol 3-kinase, mitogen-activated protein kinase, and extracellular signal-regulated kinase signaling have been proposed. 2 Since the late 1990s, it is has been recognized that PDGF-BB activates cytosolic phospholipase A2 and produces prostaglandin E 2 , resulting in G protein-coupled receptor activation and intracellular cAMP elevation. 8, 9 Although some reports suggested that PKA, a conventional downstream effector of cAMP, is activated by PDGF-BB stimulation in human arterial SMCs, 8 not much attention has been paid to the physiological or pathological roles of PDGF-BB-mediated cAMP downstream signaling pathways. To the best of our knowledge, this is the first study showing the involvement of Epac in PDGF-BB signaling pathways.
Accumulating evidence demonstrated the migratory role of Epac in various types of cells including vascular SMCs, tumor cells, fibroblasts, and leukocytes, 11, [27] [28] [29] [30] [31] although some reports showed conflicting results in epithelial cells and prostate carcinoma cells. 32, 33 Rap1, an immediate effector of Epac, has been shown to contribute to Epac-mediated cell migration. 11, 27, 31, 34 In addition, Rap1 has been demonstrated to promote cell migration via regulation of integrin and actin polymerization. [35] [36] [37] However, downstream molecular mechanisms of Epac-mediated cell migration are beginning to be relatively defined. Baljinnyam et al 29 reported Epac1-Ca 2+ -mediated migration in melanoma cells. Using various inhibitors, the authors demonstrated that Epac1 increased intracellular Ca 2+ concentration through PLCε inositol 1,4,5-triphosphate receptor signaling, which promoted actin assembly at the leading edge through Ca 2+ -binding protein S100A4-induced activation of MHCIIA (non-muscle myosin heavy chain II A). 29 In this study, we found that Epac1 activation promoted cofilin dephosphorylation, resulting in lamellipodia formation at the leading edge of SMCs, and thus migration. Cofilin is a protein belonging to the actin depolarizing factor family of proteins, and it mediates lamellipodial extension and polarized cell migration by stimulating actin-filament disassembly at the leading edge of migrating cells. [38] [39] [40] Phosphorylated cofilin is dephosphorylated by Ca 2+ -dependent serine-threonine phosphatase calcineurin to be converted to active form. 41 Calcineurin-mediated cofilin activation may be a mechanism of Epac1-induced cell migration, although this study did not show direct evidence. Previous reports suggesting that cofilin is activated under PDGF stimulation in vascular SMCs 42,43 also support our findings.
The elevation of intracellular Ca 2+ is important in cell migration. 44 It is well recognized that PLCγ contributes to PDGF-BB-induced Ca 2+ elevation. 14 Once PDGF-BB binds to PDGFR, tyrosine residues are autophosphorylated, and phosphorylated tyrosine residues located outside the kinase domain create docking sites for PLCγ that contain SH2 domains. 14 Subsequent activation of PLCγ leads to PI(4,5)P 2 hydrolysis, resulting in generation of diacylglycerol and inositol 1,4,5-triphosphate. 14 Intracellular Ca 2+ level is elevated as a result of inositol 1,4,5-triphosphate-mediated Ca 2+ release from intracellular compartments. 14 In addition to PLCγ, a recent study using PLCε-deficient fibroblasts revealed that 50% of PDGF-BB-mediated PLC activity is attributed to PLCε. 45 The authors demonstrated that the majority of the PLCε +/+ cells that migrated were biased toward the PDGF gradient, whereas PLCε-deficient cells did not exhibit directional migration. 45 However, the mechanisms of PLCε activation under PDGF stimulation have not been demonstrated. Our data suggested that Epac1 was responsible for ≈50% of the PDGF-BB-induced intracellular Ca 2+ elevation. Epac1 activates PLCε via Rap1 or Rap2 and enhances intracellular Ca 2+ release. 46 Although this study did not show direct evidence of the involvement of PLCε, Epac1 may contribute to PDGF-PLCε-induced intracellular Ca 2+ elevation. Recent studies suggest that PLCε cooperates with nuclear factor-κB to induce proinflammatory-related mediators, such as CXCL2 and cyclooxygenase 2, which are upregulated at the vascular injury site. [47] [48] [49] In addition to the potential role of PLCε in Epac1mediated migration, further studies on the roles of PLCε as a downstream signaling effector of PDGF-BB-Epac are required.
As mentioned above, Rap1 contributes to Epac1-mediated cell migration in various cell types. 11, 27, 31, 34, 50 However, a subtype-specific differential effect of Rap1 on cell migration has been reported. A study using Rap1a-deficient mice demonstrated that Rap1 reduced the ability for directed migration of monocytes toward chemokines. Severson et al 51 also demonstrated that Rap1a, but not Rap1b, promoted epithelial cell migration. However, Infante et al 52 indicated that Rap1b, but not Rap1a, inhibited migration in leukemia cells. Although a subtype-specific effect of Rap1 on vascular SMC migration has not been reported, in accordance with these previous reports on other cell types, our data showed that Rap1a was involved in PDGF-BB-induced SMC lamellipodia formation. Another line of study demonstrated that the CDC25 homology domain of PLCε, which exhibits guanine nucleotide exchange factor activity toward Rap1, is critical for the prolonged activation of PLCε under PDGF stimulation. 53 The authors also demonstrated that Rap1a, rather than Rap2a or Rap2b, is likely to be responsible for PDGF-mediated prolonged activation of PLCε signaling. 53 Because Rap1 binds the Ras/Rap1-associating domain of PLCε and induces subsequent activation of PLCε, Rap1a and PLCε seem to synergistically activate each other, thus prolonging the activation of PLCε. 53 These data support our concept that Epac1-Rap1a contributes to PDGF-mediated migration.
Epac acts independently or sometimes together with PKA. Although both PKA and Epac can be activated on cAMP production, the reported roles of PKA and Epac in vascular SMC migration and neointimal thickening opposed one another. 11, 31, 54 The activation of cAMP-PKA signaling has been reported to inhibit vascular SMC migration. 54 However, Epac activation stimulated vascular SMC migration. 11, 31 In accordance with these reports, this study demonstrated that Epac1 deficiency significantly attenuated PDGF-BB-induced migration. Under stimulation of PDGF-BB, cAMP seems to, at least in part, substantially stimulate Epac and promote migration. The opposing roles of PKA and Epac in neointima formation were also demonstrated in in vivo studies. Local administration of cAMP and phosphodiesterase inhibitor drugs to rats markedly inhibited neointima formation after balloon injury in vivo, which was completely reversed by the inhibition of PKA. 54 In contrast, Epac activation promoted intimal thickening in an organ culture of rat arteries. 11, 31 In addition, this study using Epac1 −/− mice demonstrated that Epac deficiency inhibited cofilin dephosphorylation in SMCs and neointimal thickening after intramural vascular injury, which mimicked clinical restenosis after percutaneous coronary intervention. Our previous data suggested that the expression of regulatory and catalytic subunits of PKA was downregulated after intramural vascular injury in mice in a time-dependent manner. 11 In contrast, the expression of Epac1, but not of Epac2, was increased after arterial injury. 11 A change in expression of PKA and Epac after vascular injury may lead to a preferential stimulation of Epac rather than of the PKA pathway.
The chimeric mice generated using bone marrow cell transplantation demonstrated that the genetic background of vascular tissues rather than of BMCs affected Epac1-mediated vascular remodeling. Although our data demonstrated the contribution of Epac1 of SMCs in intimal thickening, perivascular fibroblast migration has been indicated to be associated with neointimal thickening. 25 Our data showed that Epac1 deficiency attenuated PDGF-BB-induced migration in perivascular fibroblasts as well as in SMCs, suggesting the potential role of Epac1 in perivascular fibroblasts in intimal thickening in vivo. Further studies are required for understanding the cell type-specific relative contribution in Epac1-induced intimal thickening.
In conclusion, our in vitro and in vivo study data suggested that Epac plays a role in vascular SMC migration via cofilin dephosphorylation under PDGF-BB stimulation and intimal thickening after vascular injury. In addition to PDGF-BB, various G protein-coupled receptor ligands, such as catecholamine, are released at diseased vessels, 55 and inhibition of Epac1 might offer a new pharmacological therapeutic strategy for intimal thickening.
